Home The Word Brain My Amedeo FAQ Privacy About   

As of October 2023, Amedeo had
12,263 active subscribers

  Prostate Cancer

  Free Subscription


1 BMC Cancer
1 Cancer Res
3 Eur Urol
1 Int J Cancer
1 Int J Radiat Oncol Biol Phys
1 J Magn Reson Imaging
1 J Nucl Med
1 PLoS One
1 Prog Urol
3 Prostate
3 Urology

  Retrieve available abstracts of this week’s articles:
HTML format
Single Articles

    BMC Cancer

  1. HUANG L, Ma B, Zhang C, Shi J, et al
    Unveiling poly(rC)-binding protein 2 as the target protein for curcusone C against prostate cancer: mechanism validation through click chemistry-activity based proteomics profiling approach.
    BMC Cancer. 2023;23:957.
    PubMed         Abstract available

    Cancer Res

  2. RAWAT C, Ben-Salem S, Singh N, Chauhan G, et al
    Prostate cancer progression relies on the mitotic kinase citron kinase.
    Cancer Res. 2023 Oct 6. doi: 10.1158/0008-5472.CAN-23-0883.
    PubMed         Abstract available

    Eur Urol

  3. KISHAN AU, Valle LF, Marks LS
    Bullseye or Tip of the Iceberg: Magnetic Resonance Imaging-visible Disease in Radiorecurrent Prostate Cancer.
    Eur Urol. 2023 Oct 5:S0302-2838(23)03145-7. doi: 10.1016/j.eururo.2023.

  4. TRUJILLO CG, Pena Rodriguez S, Diaz Ritter C
    Re: Jean-Nicolas Cornu, Paul Zantek, Glyn Burtt, et al. Minimally Invasive Treatments for Benign Prostatic Obstruction: A Systematic Review and Network Meta-analysis. Eur Urol. 2023;83:534-47.
    Eur Urol. 2023;84:e116.

  5. FENG T, Ren M, Zhou Z
    Re: Peter Fletcher, Marta De Santis, Simona Ippoliti, et al. Vector Prostate Biopsy: A Novel Magnetic Resonance Imaging/Ultrasound Image Fusion Transperineal Biopsy Technique Using Electromagnetic Needle Tracking Under Local Anaesthesia. Eur Urol 2023
    Eur Urol. 2023;84:e114.

    Int J Cancer

  6. ALMURADOVA E, Seyyar M, Arak H, Tamer F, et al
    The real-world outcomes of Lutetium-177 PSMA-617 radioligand therapy in metastatic castration-resistant prostate cancer: Turkish Oncology Group multicenter study.
    Int J Cancer. 2023 Oct 11. doi: 10.1002/ijc.34749.
    PubMed         Abstract available

    Int J Radiat Oncol Biol Phys

  7. YOROZU A, Namiki M, Saito S, Egawa S, et al
    Tri-modality Therapy with Iodine-125 Brachytherapy, External Beam Radiation Therapy, and Short- or Long-Term Androgen Deprivation Therapy for High-Risk Localized Prostate Cancer: Results of a Multicenter, Randomized Phase 3 Trial (TRIP/TRIGU0907).
    Int J Radiat Oncol Biol Phys. 2023 Aug 24:S0360-3016(23)07843.
    PubMed         Abstract available

    J Magn Reson Imaging

  8. LIN Y, Belue MJ, Yilmaz EC, Harmon SA, et al
    Deep Learning-Based T2-weighted MR Image Quality Assessment and Its Impact on Prostate Cancer Detection Rates.
    J Magn Reson Imaging. 2023 Oct 9. doi: 10.1002/jmri.29031.
    PubMed         Abstract available

    J Nucl Med

  9. RAHBAR K, Essler M, Eiber M, la Fougere C, et al
    (177)Lu-Prostate-Specific Membrane Antigen Therapy in Patients with Metastatic Castration-Resistant Prostate Cancer and Prior (223)Ra (RALU Study).
    J Nucl Med. 2023 Oct 12:jnumed.123.266125. doi: 10.2967/jnumed.123.266125.
    PubMed         Abstract available

    PLoS One

  10. LYLES RDZ, Martinez MJ, Sherman B, Schurer S, et al
    Automation, live-cell imaging, and endpoint cell viability for prostate cancer drug screens.
    PLoS One. 2023;18:e0287126.
    PubMed         Abstract available

    Prog Urol

  11. PEYROTTES A, Roupret M, Fiard G, Fromont G, et al
    [Early detection of prostate cancer: Towards a new paradigm?].
    Prog Urol. 2023 Oct 5:S1166-7087(23)00219-1. doi: 10.1016/j.purol.2023.
    PubMed         Abstract available


  12. HOANG T, Sutera P, Nguyen T, Chang J, et al
    TP53 structure-function relationships in metastatic castrate-sensitive prostate cancer and the impact of APR-246 treatment.
    Prostate. 2023 Oct 9. doi: 10.1002/pros.24629.
    PubMed         Abstract available

  13. WANG L, Lyu C, Stadlbauer B, Buchner A, et al
    Berbamine targets cancer stem cells and reverses cabazitaxel resistance via inhibiting IGF2BP1 and p-STAT3 in prostate cancer.
    Prostate. 2023 Oct 12. doi: 10.1002/pros.24632.
    PubMed         Abstract available

  14. PEDRAZA AM, Gupta R, Musheyev D, Pino T, et al
    Microultrasound in the detection of the index lesion in prostate cancer.
    Prostate. 2023 Oct 12. doi: 10.1002/pros.24628.
    PubMed         Abstract available


  15. REZAEE ME, Gardner U, Alshak MN, Greco SC, et al
    Title: Effect of Transperineal versus Transrectal Prostate Biopsy on the Quality of Hydrogel Spacer Placement in Men prior to Radiation Therapy for Prostate Cancer.
    Urology. 2023 Oct 5:S0090-4295(23)00858-0. doi: 10.1016/j.urology.2023.
    PubMed         Abstract available

  16. PAULA DOMINO M, Vertosick EA, Vickers AJ, Eastham JA, et al
    The association between low preoperative serum testosterone and post radical prostatectomy urinary function.
    Urology. 2023 Jul 27:S0090-4295(23)00654-4. doi: 10.1016/j.urology.2023.
    PubMed         Abstract available

  17. XU AJ, Panken EJ, Gonzales-Alabastro CD, Zhang H, et al
    Urologists and Lesbian, Gay, Bisexual, Transgender, or Queer Patients: A Survey-based Study of the Practice Patterns, Attitudes, and Knowledge Base of Urologists Toward Their Lesbian, Gay, Bisexual, Transgender, or Queer Patients.
    Urology. 2023;179:71-79.
    PubMed         Abstract available

Thank you for your interest in scientific medicine.

AMEDEO Prostate Cancer is free of charge.